GPAFX
Price
$61.01
Change
-$0.04 (-0.07%)
Updated
Sep 8 closing price
Net Assets
525.82M
VVIAX
Price
$71.19
Change
-$0.24 (-0.34%)
Updated
Sep 5 closing price
Net Assets
202.84B
Interact to see
Advertisement

GPAFX vs VVIAX

Header iconGPAFX vs VVIAX Comparison
Open Charts GPAFX vs VVIAXBanner chart's image
Victory RS Large Cap Alpha A
Price$61.01
Change-$0.04 (-0.07%)
VolumeN/A
Net Assets525.82M
Vanguard Value Index Adm
Price$71.19
Change-$0.24 (-0.34%)
VolumeN/A
Net Assets202.84B
GPAFX vs VVIAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
GPAFX vs. VVIAX commentary
Sep 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GPAFX is a Buy and VVIAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VVIAX has more cash in the bank: 203B vs. GPAFX (526M). VVIAX pays higher dividends than GPAFX: VVIAX (2.10) vs GPAFX (0.87). GPAFX was incepted earlier than VVIAX: GPAFX (53 years) vs VVIAX (25 years). GPAFX (0.91) is less costly to investors than VVIAX (0.05). GPAFX is a more actively managed with annual turnover of: 27.00 vs. VVIAX (9.00). GPAFX has a lower initial minimum investment than VVIAX: GPAFX (2500) vs VVIAX (3000). VVIAX annual gain was more profitable for investors over the last year : 7.74 vs. GPAFX (-2.88). VVIAX return over 5 years is better than : 70.16 vs. GPAFX (37.77).
GPAFXVVIAXGPAFX / VVIAX
Total Expense Ratio0.890.051,780%
Annual Report Gross Expense Ratio0.910.051,820%
Fund Existence53 years25 years-
Gain YTD7.6157.85097%
Front Load6%N/A-
Min. Initial Investment2500300083%
Min. Initial Investment IRAN/AN/A-
Net Assets526M203B0%
Annual Yield % from dividends0.872.1041%
Returns for 1 year-2.887.74-37%
Returns for 3 years20.3136.6155%
Returns for 5 years37.7770.1654%
Returns for 10 years16.39131.6112%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AMCX7.560.20
+2.72%
AMC Networks
INMB1.950.03
+1.56%
INmune Bio
ACGLN18.080.19
+1.06%
Arch Capital Group Ltd
ARDX6.52-0.05
-0.76%
Ardelyx
HQY91.48-6.22
-6.37%
HealthEquity